Endocrine complications of cystic fibrosis

Antoinette Moran1

  • 1Department of Pediatrics, University of Minnesota, Minneapolis, 55455, USA.

Adolescent Medicine (Philadelphia, Pa.)
|February 14, 2002
PubMed

Insights

Cystic Fibrosis (CF) patients live longer, but face new endocrine issues like poor growth, CF-related diabetes, and bone problems. Early screening and treatment are key for managing these complications in adolescents.

Area of Science:

  • Endocrinology
  • Pulmonology
  • Pediatrics

Background:

  • Increased life expectancy in cystic fibrosis (CF) patients highlights non-pulmonary complications.
  • Improved CF treatments shift focus to other chronic health issues.
  • Endocrine complications are increasingly recognized in adolescents with CF.

Purpose of the Study:

  • To review the pathophysiology of endocrine complications in CF.
  • To outline screening protocols for endocrine dysfunction in CF.
  • To discuss current treatment strategies for CF-related endocrine issues.

Main Methods:

  • Literature review of endocrine complications in cystic fibrosis.
  • Analysis of pathophysiology, screening, and treatment guidelines.
  • Focus on adolescent patient population.

Main Results:

  • Key endocrine issues include growth failure, delayed puberty, CF-related diabetes, and poor bone mineralization.
  • Screening is crucial for early detection of endocrine abnormalities.
  • Multidisciplinary management is essential for optimal outcomes.

Conclusions:

  • Endocrine complications are significant in the growing population of long-living CF patients.
  • Proactive screening and management of endocrine issues improve quality of life.
  • Further research into CF endocrine pathophysiology and treatment is warranted.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
The Endocrine System01:29

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that every...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...